BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 21924378)

  • 1. Lack of acyl-CoA:diacylglycerol acyltransferase 1 reduces intestinal cholesterol absorption and attenuates atherosclerosis in apolipoprotein E knockout mice.
    Chandak PG; Obrowsky S; Radovic B; Doddapattar P; Aflaki E; Kratzer A; Doshi LS; Povoden S; Ahammer H; Hoefler G; Levak-Frank S; Kratky D
    Biochim Biophys Acta; 2011 Dec; 1811(12):1011-20. PubMed ID: 21924378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestine-specific DGAT1 deficiency improves atherosclerosis in apolipoprotein E knockout mice by reducing systemic cholesterol burden.
    Vujić N; Korbelius M; Sachdev V; Rainer S; Zimmer A; Huber A; Radović B; Kratky D
    Atherosclerosis; 2020 Oct; 310():26-36. PubMed ID: 32882484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel role of a triglyceride-synthesizing enzyme: DGAT1 at the crossroad between triglyceride and cholesterol metabolism.
    Sachdev V; Leopold C; Bauer R; Patankar JV; Iqbal J; Obrowsky S; Boverhof R; Doktorova M; Scheicher B; Goeritzer M; Kolb D; Turnbull AV; Zimmer A; Hoefler G; Hussain MM; Groen AK; Kratky D
    Biochim Biophys Acta; 2016 Sep; 1861(9 Pt A):1132-1141. PubMed ID: 27344248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyl-CoA:Diacylglycerol Acyltransferase 1 Expression Level in the Hematopoietic Compartment Impacts Inflammation in the Vascular Plaques of Atherosclerotic Mice.
    Vujic N; Porter Abate J; Schlager S; David T; Kratky D; Koliwad SK
    PLoS One; 2016; 11(5):e0156364. PubMed ID: 27223895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acyl-CoA:cholesterol acyltransferase inhibition reduces atherosclerosis in apolipoprotein E-deficient mice.
    Kusunoki J; Hansoty DK; Aragane K; Fallon JT; Badimon JJ; Fisher EA
    Circulation; 2001 May; 103(21):2604-9. PubMed ID: 11382731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aged Garlic Extract Suppresses the Development of Atherosclerosis in Apolipoprotein E-Knockout Mice.
    Morihara N; Hino A; Yamaguchi T; Suzuki J
    J Nutr; 2016 Feb; 146(2):460S-463S. PubMed ID: 26764329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background.
    Sontag TJ; Krishack PA; Lukens JR; Bhanvadia CV; Getz GS; Reardon CA
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):262-9. PubMed ID: 24334873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice.
    MacKinnon AC; Liu X; Hadoke PW; Miller MR; Newby DE; Sethi T
    Glycobiology; 2013 Jun; 23(6):654-63. PubMed ID: 23426722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-Term Acyl-CoA:Cholesterol Acyltransferase Inhibition, Combined with Apoprotein A1 Overexpression, Promotes Atherosclerosis Inflammation Resolution in Mice.
    Amengual J; Ogando Y; Nikain C; Quezada A; Qian K; Vaisar T; Fisher EA
    Mol Pharmacol; 2021 Mar; 99(3):175-183. PubMed ID: 33384285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrogen decreases athero-susceptibility in apolipoprotein B-containing lipoproteins and aorta of apolipoprotein E knockout mice.
    Song G; Tian H; Qin S; Sun X; Yao S; Zong C; Luo Y; Liu J; Yu Y; Sang H; Wang X
    Atherosclerosis; 2012 Mar; 221(1):55-65. PubMed ID: 22209213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
    Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
    Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired cholesterol metabolism and enhanced atherosclerosis in clock mutant mice.
    Pan X; Jiang XC; Hussain MM
    Circulation; 2013 Oct; 128(16):1758-69. PubMed ID: 24014832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlorogenic acid protects against atherosclerosis in ApoE-/- mice and promotes cholesterol efflux from RAW264.7 macrophages.
    Wu C; Luan H; Zhang X; Wang S; Zhang X; Sun X; Guo P
    PLoS One; 2014; 9(9):e95452. PubMed ID: 25187964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A salmon protein hydrolysate exerts lipid-independent anti-atherosclerotic activity in ApoE-deficient mice.
    Parolini C; Vik R; Busnelli M; Bjørndal B; Holm S; Brattelid T; Manzini S; Ganzetti GS; Dellera F; Halvorsen B; Aukrust P; Sirtori CR; Nordrehaug JE; Skorve J; Berge RK; Chiesa G
    PLoS One; 2014; 9(5):e97598. PubMed ID: 24840793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological inhibition to examine the role of DGAT1 in dietary lipid absorption in rodents and humans.
    Maciejewski BS; LaPerle JL; Chen D; Ghosh A; Zavadoski WJ; McDonald TS; Manion TB; Mather D; Patterson TA; Hanna M; Watkins S; Gibbs EM; Calle RA; Steppan CM
    Am J Physiol Gastrointest Liver Physiol; 2013 Jun; 304(11):G958-69. PubMed ID: 23558010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic CGI-58 expression in macrophages alleviates the atherosclerotic lesion development in ApoE knockout mice.
    Xie P; Zeng X; Xiao J; Sun B; Yang D
    Biochim Biophys Acta; 2014 Dec; 1841(12):1683-90. PubMed ID: 25178844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of CD73 promotes atherogenesis in apolipoprotein E-deficient mice.
    Buchheiser A; Ebner A; Burghoff S; Ding Z; Romio M; Viethen C; Lindecke A; Köhrer K; Fischer JW; Schrader J
    Cardiovasc Res; 2011 Nov; 92(2):338-47. PubMed ID: 21955554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency of endogenous acute phase serum amyloid A does not affect atherosclerotic lesions in apolipoprotein E-deficient mice.
    De Beer MC; Wroblewski JM; Noffsinger VP; Rateri DL; Howatt DA; Balakrishnan A; Ji A; Shridas P; Thompson JC; van der Westhuyzen DR; Tannock LR; Daugherty A; Webb NR; De Beer FC
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):255-61. PubMed ID: 24265416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACAT inhibition reduces the progression of preexisting, advanced atherosclerotic mouse lesions without plaque or systemic toxicity.
    Rong JX; Blachford C; Feig JE; Bander I; Mayne J; Kusunoki J; Miller C; Davis M; Wilson M; Dehn S; Thorp E; Tabas I; Taubman MB; Rudel LL; Fisher EA
    Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):4-12. PubMed ID: 23139293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical chemokine receptor 1 deficiency reduces atherogenesis in ApoE-knockout mice.
    Wan W; Liu Q; Lionakis MS; Marino AP; Anderson SA; Swamydas M; Murphy PM
    Cardiovasc Res; 2015 Jun; 106(3):478-87. PubMed ID: 25858253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.